Risk of Esophageal Adenocarcinoma Decreases With Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 10, 2014, Pages 1667-1676.e1

  Thrift, Aaron P ^a,b   Risch, Harvey A ^c   Onstad, Lynn ^a   Shaheen, Nicholas J ^d   Casson, Alan G ^e   Bernstein, Leslie ^f   Corley, Douglas A ^g   Levine, David M ^h   Chow, Wong Ho ⁱ   Reid, Brian J ^a   Romero, Yvonne ^j   Hardie, Laura J ^k   Liu, Geoffrey ^l   Wu, Anna H ^m   Bird, Nigel C ⁿ   Gammon, Marilie D ^o   Ye, Weimin ^p   Whiteman, David C ^b   Vaughan, Thomas L ^a  

^a USA   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^g DIVISION OF RESEARCH   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^j MAYO CLINIC   (United States)

^k UNIVERSITY OF LEEDS   (United Kingdom)

^l UNIVERSITY OF TORONTO   (Canada)

^m UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁿ UNIVERSITY OF SHEFFIELD   (United Kingdom)

^o University of North Carolina at Chapel Hill   (United States)

^p KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

Esophageal Cancer; Etiology; Risk Factors; Sex Differences

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; POPULATION BASED CASE CONTROL STUDY; QUANTITATIVE ANALYSIS; SEX RATIO; SMOKING; ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; EUROPE; MIDDLE AGED; RISK FACTOR; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BODY HEIGHT; ESOPHAGEAL NEOPLASMS; EUROPE; FEMALE; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; RISK FACTORS;

EID: 84908083877     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.01.039     Document Type: Article

References (38)

1. Thrift A.P., Whiteman D.C. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 2012, 23:3155-3162.
2. Cook M.B., Chow W.H., Devesa S.S. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 2009, 101:855-859.
3. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. NEngl J Med 1999, 340:825-831.
4. Hoyo C., Cook M.B., Kamangar F., et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol 2012, 41:1706-1718.
5. Kubo A., Cook M.B., Shaheen N.J., et al. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut 2013, 62:1684-1691.
6. Cook M.B., Kamangar F., Whiteman D.C., et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. JNatl Cancer Inst 2010, 102:1344-1353.
7. Cook M.B., Shaheen N.J., Anderson L.A., et al. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology 2012, 142:744-753.
8. Liao L.M., Vaughan T.L., Corley D.A., et al. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology 2012, 142:442-452.
9. Anderson L.A., Johnston B.T., Watson R.G., et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res 2006, 66:4975-4982.
10. Whiteman D.C., Parmar P., Fahey P., et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010, 139:73-83.
11. Thrift A.P., Pandeya N., Smith K.J., et al. Helicobacter pylori infection and the risks of Barrett's oesophagus: a population-based case-control study. Int J Cancer 2012, 130:2407-2416.
12. Green J., Cairns B.J., Casabonne D., et al. Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 2011, 12:785-794.
13. Walter R.B., Brasky T.M., Buckley S.A., et al. Height as an explanatory factor for sex differences in human cancer. JNatl Cancer Inst 2013, 105:860-868.
14. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 2012, 41:1419-1433. The Emerging Risk Factors Collaboration.
15. Davey Smith G., Hart C., Upton M., et al. Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality. JEpidemiol Community Health 2000, 54:97-103.
16. Leoncini E., Ricciardi W., Cadoni G., et al. Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium. Eur J Epidemiol 2014, 29:35-48.
17. Lagergren J., Bergstrom R., Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999, 130:883-890.
18. Chow W.H., Blot W.J., Vaughan T.L., et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. JNatl Cancer Inst 1998, 90:150-155.
19. O'Doherty M.G., Freedman N.D., Hollenbeck A.R., et al. Aprospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut 2012, 61:1261-1268.
20. Engeland A., Tretli S., Bjorge T. Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women. Cancer Causes Control 2004, 15:837-843.
21. Jacobson B.C., Chan A.T., Giovannucci E.L., et al. Body mass index and Barrett's oesophagus in women. Gut 2009, 58:1460-1466.
22. Stein D.J., El-Serag H.B., Kuczynski J., et al. The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther 2005, 22:1005-1010.
23. Davey Smith G., Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol 2003, 32:1-22.
24. Lawlor D.A., Harbord R.M., Sterne J.A., et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008, 27:1133-1163.
25. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000, 29:722-729.
26. Davey Smith G., Lawlor D.A., Harbord R., et al. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med 2007, 4:e352.
27. Davey Smith G., Ebrahim S. What can Mendelian randomisation tell us about modifiable behavioural and environmental exposures?. BMJ 2005, 330:1076-1079.
28. Levine D.M., Ek W.E., Zhang R., et al. Agenome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet 2013, 45:1487-1493.
29. Kabat G.C., Heo M., Miller A.B., et al. Scaling of weight for height in relation to risk of cancer at different sites in a cohort of Canadian women. Am J Epidemiol 2013, 177:93-101.
30. Palmer T.M., Sterne J.A., Harbord R.M., et al. Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am J Epidemiol 2011, 173:1392-1403.
31. Staiger D., Stock J.H. Instrumental variables regression with weak instruments. Econometrica 1997, 65:557-586.
32. Baum C.F., Schaffer M.E., Stillman S. Instrumental variables and GMM: estimation and testing. Stata J 2003, 3:1-32.
33. Kabat G.C., Heo M., Kamensky V., et al. Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 2013, 132:1125-1132.
34. Albanes D., Winick M. Are cell number and cell proliferation risk factors for cancer?. JNatl Cancer Inst 1988, 80:772-774.
35. Hwang A.E., Mack T.M., Hamilton A.S., et al. Childhood infections and adult height in monozygotic twin pairs. Am J Epidemiol 2013, 178:551-558.
36. Thrift A.P., Kendall B.J., Pandeya N., et al. Aclinical risk prediction model for Barrett esophagus. Cancer Prev Res 2012, 5:1115-1123.
37. Rubenstein J.H., Morgenstern H., Appelman H., et al. Prediction of Barrett's esophagus among men. Am J Gastroenterol 2013, 108:353-362.
38. Thrift A.P., Kendall B.J., Pandeya N., et al. Amodel to determine absolute risk for esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2013, 11:138-144.